StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of NASDAQ:SRNE opened at $0.01 on Monday. The business’s 50-day moving average is $0.02 and its 200-day moving average is $0.05. […]
StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of SRNE stock opened at $0.02 on Friday. The firm’s 50 day moving average price is $0.02 and its two-hundred […]
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of NASDAQ SRNE opened at $0.02 on Friday. Sorrento Therapeutics has a 52 week low of $0.00 and a […]
Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) and Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Analyst Ratings This is a summary of […]
Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.10 and traded as low as $0.02. Sorrento Therapeutics shares last traded at $0.05, with a volume of 956,943 shares traded. Analyst Ratings Changes Separately, StockNews.com initiated […]